287 related articles for article (PubMed ID: 36007534)
21. Pregabalin: new drug. Very similar to gabapentin.
Prescrire Int; 2005 Dec; 14(80):203-6. PubMed ID: 16397976
[TBL] [Abstract][Full Text] [Related]
22. Pregabalin for neuropathic pain in adults.
Derry S; Bell RF; Straube S; Wiffen PJ; Aldington D; Moore RA
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD007076. PubMed ID: 30673120
[TBL] [Abstract][Full Text] [Related]
23. Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: data from the randomized, double-blind, COMBO-DN study.
Bouhassira D; Wilhelm S; Schacht A; Perrot S; Kosek E; Cruccu G; Freynhagen R; Tesfaye S; Lledó A; Choy E; Marchettini P; Micó JA; Spaeth M; Skljarevski V; Tölle T
Pain; 2014 Oct; 155(10):2171-9. PubMed ID: 25168665
[TBL] [Abstract][Full Text] [Related]
24. Duloxetine in patients with diabetic peripheral neuropathic pain in Japan: a randomized, doubleblind, noninferiority comparative study with pregabalin.
Enomoto H; Yasuda H; Nishiyori A; Fujikoshi S; Furukawa M; Ishida M; Takahashi M; Tsuji T; Yoshikawa A; Alev L
J Pain Res; 2018; 11():1857-1868. PubMed ID: 30271191
[TBL] [Abstract][Full Text] [Related]
25. Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial.
Horne AW; Vincent K; Hewitt CA; Middleton LJ; Koscielniak M; Szubert W; Doust AM; Daniels JP;
Lancet; 2020 Sep; 396(10255):909-917. PubMed ID: 32979978
[TBL] [Abstract][Full Text] [Related]
26. Investigation of the Combination of Pregabalin with Duloxetine or Amitriptyline on the Pharmacokinetics and Antiallodynic Effect During Neuropathic Pain in Rats.
Rodrigues RF; Kawano T; Placido RV; Costa LH; Podesta MHMC; Santos RS; Galdino G; Barros CM; Boralli VB
Pain Physician; 2021 Jul; 24(4):E511-E520. PubMed ID: 34213877
[TBL] [Abstract][Full Text] [Related]
27. Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?
Marchettini P; Wilhelm S; Petto H; Tesfaye S; Tölle T; Bouhassira D; Freynhagen R; Cruccu G; Lledó A; Choy E; Kosek E; Micó JA; Späth M; Skljarevski V; Lenox-Smith A; Perrot S
Eur J Pain; 2016 Mar; 20(3):472-82. PubMed ID: 26311228
[TBL] [Abstract][Full Text] [Related]
28. Medication adherence and healthcare costs among patients with diabetic peripheral neuropathic pain initiating duloxetine versus pregabalin.
Zhao Y; Sun P; Watson P
Curr Med Res Opin; 2011 Apr; 27(4):785-92. PubMed ID: 21303196
[TBL] [Abstract][Full Text] [Related]
29. Combination pharmacotherapy for the treatment of fibromyalgia in adults.
Thorpe J; Shum B; Moore RA; Wiffen PJ; Gilron I
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD010585. PubMed ID: 29457627
[TBL] [Abstract][Full Text] [Related]
30. Study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled phase III trial investigating additive efficacy of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: the DIRECT study.
Matsuoka H; Ishiki H; Iwase S; Koyama A; Kawaguchi T; Kizawa Y; Morita T; Matsuda Y; Miyaji T; Ariyoshi K; Yamaguchi T
BMJ Open; 2017 Aug; 7(8):e017280. PubMed ID: 28851798
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of Pregabalin Compared to Duloxetine in Diabetic Peripheral Neuropathic Pain: An Observational Study.
Jha S; Sahani OP; Siddiqui S; Verma MK; Mazumder A; Waghdhare S
J Assoc Physicians India; 2019 Nov; 67(11):32-36. PubMed ID: 31793266
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Curr Med Res Opin; 2009 Jul; 25(7):1677-87. PubMed ID: 19480610
[TBL] [Abstract][Full Text] [Related]
33. Amitriptyline vs. pregabalin in painful diabetic neuropathy: a randomized double blind clinical trial.
Bansal D; Bhansali A; Hota D; Chakrabarti A; Dutta P
Diabet Med; 2009 Oct; 26(10):1019-26. PubMed ID: 19900234
[TBL] [Abstract][Full Text] [Related]
34. Combination pharmacotherapy for the treatment of neuropathic pain in adults.
Chaparro LE; Wiffen PJ; Moore RA; Gilron I
Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD008943. PubMed ID: 22786518
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of mirogabalin (DS-5565) for the treatment of diabetic peripheral neuropathic pain: a randomized, double-blind, placebo- and active comparator-controlled, adaptive proof-of-concept phase 2 study.
Vinik A; Rosenstock J; Sharma U; Feins K; Hsu C; Merante D;
Diabetes Care; 2014 Dec; 37(12):3253-61. PubMed ID: 25231896
[TBL] [Abstract][Full Text] [Related]
36. Factors associated with pain medication selection among patients diagnosed with diabetic peripheral neuropathic pain: a retrospective study.
Chen S; Wu N; Boulanger L; Fraser K; Zhao Z; Zhao Y
J Med Econ; 2011; 14(4):411-20. PubMed ID: 21615268
[TBL] [Abstract][Full Text] [Related]
37. Dosing pattern comparison between duloxetine and pregabalin among patients with diabetic peripheral neuropathic pain.
Sun P; Zhao Y; Zhao Z; Bernauer M; Watson P
Pain Pract; 2012 Nov; 12(8):641-8. PubMed ID: 22335435
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens.
Freynhagen R; Strojek K; Griesing T; Whalen E; Balkenohl M
Pain; 2005 Jun; 115(3):254-263. PubMed ID: 15911152
[TBL] [Abstract][Full Text] [Related]
39. Suboptimal Treatment of Diabetic Peripheral Neuropathic Pain in the United States.
Yang M; Qian C; Liu Y
Pain Med; 2015 Nov; 16(11):2075-83. PubMed ID: 26118704
[TBL] [Abstract][Full Text] [Related]
40. Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocol.
Matsuoka H; Clark K; Fazekas B; Oyamada S; Brown L; Ishiki H; Matsuda Y; Hasuo H; Ariyoshi K; Lee J; Le B; Allcroft P; Kochovska S; Fujiwara N; Miyaji T; Lovell M; Agar M; Yamaguchi T; Satomi E; Iwase S; Phillips J; Koyama A; Currow DC
BMJ Open; 2022 Feb; 12(2):e050182. PubMed ID: 35131817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
